Skip to main content
Iranian Journal of Microbiology logoLink to Iranian Journal of Microbiology
. 2025 Feb;17(1):113–121. doi: 10.18502/ijm.v17i1.17808

Investigation of new exopolysaccharides produced by strains of donkey milk

Arevik Israyelyan 1,*, Tsovinar Balabekyan 1, Lara Aleksanyan 1, Inesa Sahakyan 2, Anna Gasparyan 1, Flora Tkhruni 1
PMCID: PMC12049757  PMID: 40330065

Abstract

Background and Objectives:

It has been shown that strains of the genus Enterococcus isolated from donkey milk from different regions of the Republic of Armenia have antimicrobial activity, synthesize different polysaccharides and produce disaccharide polymers (glucose and galactose). The quantitative synthesis of polysaccharides (8–15%) depends on the composition of the nutrient medium, temperature and growing time.

Materials and Methods:

Species identification of LAB strains was confirmed by 16S rDNA gene sequencing method using universal primers LAB strains. The methods used for extraction, purification and detection of exopolysaccharides are based on the method of Sørensen et al. (2022). The antibacterial activity of EPS was investigated by agar diffusion assay. Determination of the immunostimulating property was carried out using the ELISA method.

Results:

The antimicrobial activity of the polysaccharide and antimicrobial protein-like fractions of the genus Enterococcus strains depends on its concentration, time of interaction with the test culture, and the species of the pathogenic bacteria.

Conclusion:

The obtained results were shown that strains isolated from fermented donkey milk that are capable of synthesizing two substances of different nature with high antimicrobial properties during the growth process are promising for further research and application for their use as probiotics and biopreparations in pharmaceuticals.

Keywords: Exopolysaccharides, Protein-like fractions, Interaction, Donkey milk, Antimicrobial activity

INTRODUCTION

In recent years, much attention has been paid to products of biologically active compounds synthesized by lactic acid bacteria (LAB) isolated from the milk of different animals (1, 2).

Matsoon (national product of Armenia) is characterized by more abundant microflora representing different microbial species and their symbiotic associations. It is essentially important that the microbial composition of Matsoon starters and of the final product itself significantly differs from various Caucasian areas but is very stable and characteristic for the region originated. Due to the region and milk used, the qualitative and quantitative composition of Matsoon microflora significantly differs. It permits to isolate new microbial forms and their associations adapted and stabilized for many years to certain ecological and geographical conditions (3).

Currently the development of concepts for the use of probiotics also includes the production and use of metabiotics. Metabiotics of LAB can contain bacteriocins with antimicrobial activity against multidrug-resistant bacteria and other low molecular weight antimicrobial molecules, short-chain fatty acids, exopolysaccharides, antioxidants, different proteins, including enzymes, peptides with various activities, amino acids, and others (4, 5). In recent years, we have been focused on the research of the metabiotics of synthesized LAB. Metabiotics are structural components of probiotic microorganisms and their metabolites, or signal molecules with a certain chemical structure that are formed during their growth.

Antimicrobial peptides such as bacteriocins produced by some bacteria, can serve as the basis for serious consideration as an alternative to traditional antibiotics. These molecules have significant activity against other bacteria (including strains resistant to antibiotics), are stable, and can have a narrow or wide range of activity. Bacteriocins can even be made in intestines by probiotic bacteria and struggle with intestinal infections without affecting microflora harmlessly (6).

Various researchers showed that lactic acid bacteria (LAB) have great potential for the synthesis of exopolisaccharides (EPS). Some of them contribute to the selective growth of lactic acid bacteria and bifidobacteria by playing a role in the microbiota and the host’s immune system (7, 8). EPS, produced by the LAB, attracts more and more attention, mainly due to their advantages for health, such as immune stimulation, antimutagenic activity, increased content of antioxidants and antitumor activity, and reducing cholesterol levels (911).

Different researchers have shown that lactobacilli have great potential for the synthesis of exopolysaccharides; however, the functions of these biopolymers are not fully understood, although there are enough studies on their use in food (12, 13). The exopolysaccharides are thought to play a significant role in the colonization of lactic acid bacteria to various ecosystems by facilitating the colonization of bacteria to intestinal mucosa, thus enhancing the immunity of the host (14). Nowadays, the exopolysaccharides are used as bio-thickeners due to their stabilizing, emulsifying, or gelling properties, especially in the food industry (15). Recently, EPS produced by LAB have received increasing attention, mainly because of their health benefits,in particular, immune stimulation, antimutagenicity, antioxidants, and the antitumor activity of fermented dairy products prepared with EPS-producing LAB.

In recent decades, the immunomodulatory potential of EPSs has received a lot of scientific consideration. Many in vitro studies have demonstrated that EPSs produced by different LAB species have immunomodulatory ability (16). The phosphate group (a good inducer of the immune response) plays a critical role and characterizes the immunomodulatory effects of EPSs. Phosphate molecules can activate various immune cells (such as macrophages and lymphocytes) and initiate immune responses. According to these results, it can be speculated that EPS generated under acid stress may exhibit stronger immunological properties (17). The immunoregulatory function of EPS strongly correlates with the chemical structure and configuration of these bacterial exopolysaccharides. Another health-promoting function of EPSs produced by LAB are cholesterol-lowering effects. In an in vitro assay, EPSs produced by L. plantarum BR2 showed cholesterol-lowering properties (45%). Based on animal and in vitro experiments, several hypotheses to explain the cholesterol-lowering mechanism of EPSs have been proposed, including bile removal, anabolism, cholesterol conversion, and co-precipitation effects (18, 19). LAB-EPS can improve intestinal health by adhering to intestinal epithelial cells, restoring impaired intestinal barrier function, and inhibiting biofilm formation by bacterial pathogens. LAB-EPS has also been found to regulate the immune system by boosting the proliferation of T/B lymphocytes, natural killer cell tumoricidal activity, mitogenic activity, mononuclear cell phagocytic capacity, and inducing cytokines, therefore enhancing the host immune response to pathogens (20, 21).

EPS produced by LAB varies widely in structure, and understanding these differences is key to assessing EPS functionality. In this study, 201 LAB strains were evaluated for heteropolysaccharide production, with the following LAB strains evaluated for EPS production: Lactobacillus (L.) delbrueckii subsp. bulgaricus, L. delbrueckii subsp. lactis, L. helveticus, L. casei, L. paracasei, L. rhamnosus, Enterococcus (Ent.) faecalis, Ent. faecium, and Streptococcus thermophilus. This study highlighted the great structural diversity and molecular weight differences (from 8 kDa to 5000 kDa) of heteropolysaccharides (22, 23). The results have shown that the most frequently encountered species are Lactobacillus paracasei, Lactococcuslactis, and Carnobacterium maltaromaticum, less Leuconostoc, Enterococcus, Streptococcus, and yeast Kluyveromyces marxianus (24). We have shown that the LAB strains were mainly presented with several species of Enterococcus genus. The isolated LAB from fermented milk of different domestic animals (cow, sheep, donkey, buffalo, goat) and hand-selected LAB were mainly represented by the genus Enterococcus. It was shown that the supernatant selected strains inhibit the growth of gram-negative, gram-positive bacteria, and some pathogenic bacteria (25).

The data of the study of the properties of the LAB isolated from domestic animal milk (in particular) are limited in the literature. The donkey’s milk is indispensable for the treatment of pneumonia, bronchitis, and diseases of respiratory paths (26, 27).

The aim of this work is to study the probiotic properties and the ability to synthesize polysaccharides-EPS and AMP (antimicrobial preparations)-containing bacteriocins (protein-like substances) by endemic strains of LAB of the genus Enterococcus, isolated from fermented donkey milk.

MATERIALS AND METHODS

Microbial strains and growth media.

The endemic LAB cultures were isolated from various samples of donkey’s milk from rural households of several regions of Armenian highlands. Samples were collected in sterile small bottles and stored at 4°C in the laboratory until they were used in experiments. A serially diluted sample was spread on MRS agar (Merck, Germany) and hydrolyzed milk agar (1.2% w/v) and cultivated at 37°C. Different morphotypes of colonies were selected and obtained pure cultures were characterized according to standard methods for lactic acid bacteria. Pure cultures of LAB were maintained as frozen stocks at −20°C in the MRS broth containing 40% glycerol. Before use, they were transferred twice into the appropriate medium and incubated during 48 hours in temperature controlled conditions in thermostat at 37°C. The strains Enterococcus and Lactobacillus were taken from Microbial Culture Collection of the Microbial Depository Center (MDC) at the SPC “Armbiotechnology” NAS RA. Species identification of LAB strains was confirmed by 16S rDNA gene sequencing method using universal primers LAB strains, and marker Gen ladder (100 bp, plus 1.5 kb, GENAXXON, Bioscience). Nucleotide sequence of the obtained amplified 16S rDNA was determined by “MACROGEN” (Korea). Strain identification was performed using the online BLAST software (www.ncbi.nlm.nih.gov/BLAST).

Inoculum preparation and obtaining of cell-free culture broth.

The strains were grown in five ml of MRS broth (37°C, 24 h) and then transferred into a 100 ml Erlenmeyer’s flask containing 50 ml of nutrient media and incubated overnight at different values of temperature and time in the thermostat.

For cultivation of LAB strains, the following nutrient media were used: Media№1. The nutrient media prepared on the basis of curd whey (28). Media№2. MRS and broth (Merck (Germany), ISO (Italy), Hi-Media (India)).

Growing LAB.

50 ml of the obtained inoculums were transferred into 100 ml of media in a 0.5L Erlenmeyer flask and grown at different values of temperature and time in the thermostat. At the end of culture, growth cell concentration achieved (7 ± 2) × 108 CFU/ml (of titration) and pH reduced to 3.5–4.2. After the end of growth, culture broth was centrifuged at 5,000 rpm for 20 min and obtained cell-free culture broth (CFC×5), which was used for future purification.

Obtaining the culture liquid.

The 16–24-hour inoculant of the LABs will be added in the amount of 10% in test tubes containing the nutrient medium prepared on the basis of milk serum with a volume of 200 ml. During combined cultivation of LAB, the strains were grown under anaerobic conditions in 100-ml volume Erlenmeyer flasks containing 50 ml of liquid medium (5% v/v) at 37°C for 48 hrs. At the end of growth, culture liquid was centrifuged at 6,000 g for 20 min at +4°C, and the cell-free culture liquid (CFC liquid) was used for future purification.

Purification of CFC liquids and isolation of protein fractions.

CFC liquids were concentrated 5 ± 0,5 times (CFC×5) on a rotary evaporator at 50°C and residual pressure 0.01 MPa (DM = 8–12%). Concentrated supernatants were treated with cooled ethanol (96%) to the extent of 30–50% saturation with constant stirring using a magnetic stirrer (29, 30). Samples, treated with ethanol, were kept for 24 h at +40°C for precipitation and then centrifuged at 10,000 g at +4°C for 10 min. Ethanol was removed by evaporation until reaching the initial volume of CFC liquid. Obtained partially purified CFC×5 liquids were fractioned by gel filtration method on the column with Sephadex G-25(1.5×57 cm, resin vol: 100 mL). Fractions displaying bactericidal properties were pooled and vacuum evaporated at temperature 50–55°C, residual pressure 0.01 MPa. Aliquots (N = 30–50) of 5 ml were collected during gel-filtration purification of each cell-free culture broth (CFC×5) to check the density of each aliquot (230–260–320 nm, mg/ml, 2800 WV/VIS by spectrophotometer). The content of dry matter (DM) of the obtained partially purified antimicrobial preparation reached 30% (IFT 10HP Reichert Refractometer).

Isolation and purificationof exopolysaccharides.

For isolation of EPS, cell-free culture broth was treated with 10% trichloroacetic acid and kept in the refrigerator at +4°C for 24 hours. Then the sediment was removed by centrifugation at 6.000 g during 20 min. The cooled ethanol (96%) in a ratio of 1:3 was added to supernatants and kept in the refrigerator at +4°C for 24 hours. After which sediment (exopolysaccharide) was removed from supernatants by centrifugation at 6.000 g for 20 min. Obtained EPS was kept in the thermostat at 50°C until it reached a constant mass. Dry powder of EPS was resolved in sterile water and 20% EPS liquids (5 mL) were passed through a column filled with Sephadex G50 resin (Sigma Aldrich) (1.5×57 cm, volume: 100 mL). The elution was carried out by sterile distilled water. Each fraction (n=45) eluted from the column, was tested for antibacterial activity on B. subtilis G 17–89 and S. typhimurium G 38 test cultures. EPS concentration of fractions was detected on 2800 Scanning UV/visible Spectrophotometer (Cole Parmer USA) at 200–600 nm). Fractions displaying bactericidal properties were pooled and vacuum evaporated at a temperature of 55°C, residual pressure 0.01 MPa. Obtained EPS preparation has antimicrobial activity at 500–700 AU/ml, pH=4.2–5.0 depending on the strain.

Test cultures.

Conditionally pathogenic gram-positive Bacillus subtilis G 17–89 and gram-negative Salmonella typhimurium G38 from the collection of bacteria of RA NAS “Armbiotechnology” were used. Bacteria were grown on nutrient agar (Himedia, India) at pH 7.2 for 16 hours and at 37°C. Pathogenic bacteria were isolated from different patients from Infection Hospitals (Armenia and Nagorno Karabakh). Antibiotic resistance of pathogenic strains was determined in the Institute of Epidemiology, Microbiology and Parasitology of Ministry of Health of Armenia and in the Stepanakert Center for Hygiene and Epidemiology. Bacteria were grown on Nutrient agar (Hi-media, India) at pH 7.2 for 16 hours and at 37°C, then harvested and suspended in the Nutrient broth at 2.2 × 106 CFU/ml.

Determination of the immunostimulating.

Property was carried out using the ELISA method (31).

RESULTS

The comparative results of synthesis polysaccharide by probiotic strains of the genus Lactobacillus and Enterococcus are shown in Table 1.

Table 1.

The antimicrobial activity of supernatants (CFC×5) and polysaccharides (test culture S. typhimurium G-38, 48h, 30°C, medium №1)

Genus of the strains N The polysaccharides Total antimicrobial activity of the supernatants (×5), AU/ml

Yield,% Total antimicrobial activity, AU/ml Growth inhibition of test culture,%
Lactobacillus 17 5–10 1500–2000 30–40 20000
Enterococcus 21 10–15 1500–3500 60–70 25000

As can be seen, the synthesis of polysaccharides and their antimicrobial activity are higher in strains of the genus Enterococcus isolated from the milk of different domestic animals (sheep, donkey, buffalo, goat) from the various regions of RA. Despite the same high antimicrobial activity, the isolated polysaccharides of the strains have different efficiency in inhibiting the growth of test cultures. To evaluate the properties of polysaccharides, selected strains isolated from donkey milk of the genus Enterococcus with probiotic properties synthesized polysaccharides.

Fig. 1 shows the results of the yields of polysaccharides (EPS) and the antimicrobial activity of concentrates of supernatants CFC×5 (AMP) as an example strains Ent. faecium KE-5 and Ent.durans KE-6 under different growing conditions (nutrient medium, different growing temperatures).

Fig. 1.

Fig. 1.

Antimicrobial activity of supernatants (CFC×5) and yield of polysaccharides in different medium

The greatest antimicrobial activity concentrates of the studied strains occurs after growing at 42°C temperature, but increased polysaccharide synthesis is observed in the studied strains when grown at 30°C. This pattern was also obtained for other strains of this genus isolated from the milk of different animals. Studies have shown that adding №1 0.5–1% peptone, 0,5% tryptone to the nutrient medium significantly increases the synthesis of polysaccharide of all studied strains with high antimicrobial activity. Adding lactose concentrations (2–8%) and increasing ammonium sulfate to 1.5% did not lead to increase in antimicrobial activity and the synthesis of polysaccharides. A number of authors such as Sørensen et al., reported that different strains, depending on the composition of the nutrient medium, synthesize different amounts of polysaccharides.

We investigated the antimicrobial activity in the concentrated supernatants (CFC×5) of strains containing protein-like substances (AMP) after the purification by gel filtration method on Sephadex G-25. Purification and isolation of polysaccharides were carried out using the gel filtration method on Sephadex G-50. Isolated polysaccharides from the supernatants (CFC×5) of the strains Ent. durans KE-6 and Ent. faecium KE-9 did not show antimicrobial activity unlike the strain Ent. faecium KE5, but the AMP of these strains suppresses the growth of test cultures with high antimicrobial activity. We investigated the ability of some strains with probiotic properties to synthesize polysaccharides by using the HPLC analytical method. It was shown that polysaccharide, isolated from cultural liquid of investigated probiotic strains, consists of glucose and galactose molecules, which is the characteristic of polysaccharides in most lactic acid bacteria (32).

Previously it was shown that the AMP (100 AU/ml) of some probiotic strains of the genus Enterococcus and Lactobacillus with antimicrobial activity were tested for their ability to inhibit the growth of antibiotic-resistant strains of Klebsiella pneumonia (n = 15), Ps. aeruginosa (n = 15), Staph. aureus (n = 15), Pr. vulgaris (n = 15), E. coli (n = 20), and Pr. mirabilis (n = 18). It was shown that the biological metabiotics of different LAB strains inhibited the growth of pathogenic bacteria with different efficiency, and it depends on sources of pathogen isolation. As a result Ent. faecium KE-5 (100 AU/ml) which suppresses the growth of the studied antibiotic-resistant strains with almost the same efficiency (90%) was selected.

The results of the study showed that purified polysaccharides of the genus Enterococcus of species faecium inhibit the growth of bacteria causing pneumonia with varying efficiency at the concentrations used (10, 20%) depending on the source of their isolation (Table 2).

Table 2.

Inhibition of growth of some pathogenic bacteria by polysaccharide of strains Ent. faecium (Ø,mm)

Polysaccharide Solution % Kl.pneumonia c-5 St. pneumonia fl-67 St. pneumonia fl-24 St. pneumonia fl-76


Strains Blood Mucus of the nasopharynx Sputum Mucus of the nasopharynx
1. Ent. faecium KE-13 19 ± 1 19 ± 1 20 ± 1 15 ± 2
2. Ent. faecium KE-5 20 18 ± 1 20 ± 1 20 ± 1 22 ± 1
3. Ent. faecium KE-14 17 ± 2 22 ± 1 20 ± 1 17 ± 2
4. Ent. faecium KE-13 16 ± 2 10 ± 2 10 ± 2 10 ± 2
5. Ent. faecium KE-5 10 19 ± 2 19 ± 1 20 ± 1 20 ± 1
6. Ent. faecium KE-14 18 ± 1 15 ± 2 16 ± 2 10 ± 2

Inhibition of the growth of pathogenic bacteria with obtained polysaccharides (100 AU/ml) is depended on the species of bacteria too. It is possible that this could be associated with the active centers in the glucose configurations in the polysaccharide composition, which requires further research. A number of scientists such as Israyelyan et al. suggest that the biological specificity of polysaccharides is associated with the structure of the polysaccharides. Protein-like substances of strain Ent. faecium K-5 (500 AU/ml) were introduced into a water solution with a Salmonella typhimurium G-38 culture, a drop in the titer of S. typhimurium G-38 was observed in 5 hours by 7log10 degree at a drug 500 AU/ml and by 3 log10 degree at an activity of 100 AU/ml within 1 hour of exposure (Fig. 2).

Fig. 2.

Fig. 2.

Salmonella typhimurium G-38 growth inhibition by different concentrations of polysaccharide of Ent. faecium KE-5 strain

Determination of the dependence of the influence of the polysaccharide on time and its concentration in a solution with a culture of S. typhimurium G-38 showed that a 10% aqueous solution of the polysaccharide strain solution Ent. faecium KE-5 inhibits the growth of S. typhimurium G-38 strain by 5log10 degree in 5 hours. Microscopy showed that in this case there is a change in the morphology of Salmonella cells (Fig. 2).

The growth inhibitory effect of S. typhimurium G-38 depends on the concentration of the polysaccharide. For comparison, we previously published data showing that protein-like substances (bacteriocins) of strains of the genus Lactobacillus and Enterococcus exhibit antimicrobial properties at a concentration of 100 AU/ml for 1 hour (24).

Was studied comparative effect of the adhesiaon the epithelium of the oral mucosa under the microscope addition polysaccharides of strains L. rhamnosus 2012 and L. plantarum 66. Polysaccharides isolated from the CL of strains Ent. faecium KE-5 and Ent. durans KE-6 stimulates the adhesion of lactic acid bacteria L. rhamnosus 2012 and L. plantarum 66. But polysaccharides obtained from strains of Ent. faecium KE-13 and Ent. faecium KE-14 do not significantly affect the manifestation of adhesion.

Immunological properties were conducted using cytokines (IL-10, IL-6, IL-8) by the ELISA method and using the test system: ZAO Vector-Best (Novosibirsk), OOO Cytokin (St. Petersburg). The immunomodulatory properties of a particular strain were determined by the spectrum and intensity of cytokine production. Interleukin-8 is known as a typical anti-inflammatory cytokine. Preliminary positive results were obtained in the model of blood erythrocytes on the stimulation of interleukin-8 secretion by polysaccharides of the Ent. faecium KE-5 strain. The polysaccharide of the strain of Ent. faecium KE-5 showed the greatest immunomodulatory activity compared to other studied polysaccharides of strains L. rhamnosus 2012, L. brevis AG 31-9, Ent. durans KE-6, Ent. faecium KE-13.

Of interest was the possibility of interaction and influence of two purified metabiotics (polysaccharides, AMP) synthesized by the selected strains of LAB isolated from different donkey milk in vitro for their further joint use as biopreparations in pharmaceuticals. For this purpose, the isolated bacterial polysaccharides in the form of aqueous solutions were mixed in vitro in a ratio of 1:1 (by volume) at a temperature of 30°C, pH 4.0–4.5, contact time 5 min. AMP of different strains (N = 5) of the genus Enterococcus (activity is 1100–3900 AU/ml) and EPS of the strains L. rhamnosus 2012 (activity is 500 AU/ml) were used (Table 3).

Table 3.

Interaction of AMP of genus Enterococcus with different EPS (in vitro)

AMP AMP Enterococcus AMP Enterococcus +EPS L. rhamnosus 2012 % AMP Enterococcus +own EPS %


AU/ml S. typhimurium G 38 AU/ml S. typhimurium G 38
1. Ent. faecium KE5 3900 1600 59↓ 2600 33↓
2. Ent. faecium KE13 1100 1000 10↓ 1000 10↓
3. Ent. faecium KE14 2500 2400 4↓ 1800 28↓
4. Ent.faecium KE18 2400 3000 20↑ 2000 17↓
5. Ent.durans KE6 1200 500 59↓ 500 59↓

Inhibition of test culture growth when containing a mixture of protein-like substances (AMP) of the genus Enterococcus and different polysaccharides of different strains in a given proportion in a solution leads to a decrease in the antimicrobial activity index to varying degrees. It is possible that the growth suppression effect on S. typhimurium G 38 bacteria with polysaccharides isolated from different origins strains of donkey milk (genus Enterococcus and Lactobacillus) is interacted with the structural features of AMP (protein-like substances) and polysaccharides.

DISCUSSION

For the first time the comparative difference in synthesis and antimicrobial activity of strains of the genus Enterococcus and Lactobacillus isolated from fermented milk of different animals was shown, besides this was shown that strains of the genus Enterococcus are more promising for their further use as probiotics, since they at the same time synthesize two metabiotics (bacteriocins and EPS) with antimicrobial properties. The dependence of polysaccharide synthesis on the composition of the medium used and the temperature of cultivation was shown, which was also noted by a number of authors such as Sørensen et al. These properties do not depend on the genus affiliation of the strains. The obtained data on the interaction of AMP and polysaccharides indicate a possible different mechanism of interaction of metabolic products in vitro, possibly due to the structural features of the polysaccharide and the type of lactic acid bacteria. Of particular interest is the study of the interaction of metabiotics (AMP and EPS) synthesized by LAB strains in the culture liquid. Interaction can be associated with the physicochemical, structural, mechanical properties of polysaccharides and protein-like substances, which is the subject of our further studies using HPLC methods, X-ray structural analysis and electron microscopy, determination of their molecular weights and the features of their effect on the cell membrane.

CONCLUSION

The obtained results showed that strains isolated from fermented donkey milk are capable of synthesizing two substances of different nature with high antimicrobial properties during the growth process, which are promising for further research and application for their use as probiotics and biopreparations in pharmaceuticals.

ACKNOWLEDGEMENTS

This research was supported by the MESCS Science Committee of RA, in the frames of the project scs 23T-AA-002.

REFERENCES

  • 1.Carminati D, Tidona F, Fornasari ME, Rossetti L, Meucci A, Giraffa G. Biotyping of cultivable lactic acid bacteria isolated from donkey milk. Lett Appl Microbiol 2014; 59: 299–305. [DOI] [PubMed] [Google Scholar]
  • 2.Karapetyan K, Tkhruni F, Chitchyan К, Balabekyan Ts, Khachatryan T, Verdyan A. (2020). Using of Lactic Acid Bacteria for Biopreservation of Dairy Products. International Conference on Biotechnology and Health (ICBH) pp: 84–85. [Google Scholar]
  • 3.Afrikian E. Studies of lactic-acid bacteria in Armenia with emphasis on radioprotective properties. Environ Syst Decis 2012; 32: 256–268. [Google Scholar]
  • 4.Shenderov BA. Metabiotics: Novel idea or natural development of probiotic conception. Microb Ecol Health Dis 2013; 24: 10.3402/mehd.v24i0.20399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Tkhruni FN, Israyelyan AL, Karapetyan KR, Balabekyan Ts R, Khachatryan LM, Khachatryan TV. Comparative antimicrobial activity of some metabiotics synthesized by lactic acid bacteria. New Armen Med J 2023; 17: 98–109. [Google Scholar]
  • 6.Mokoena MP. Lactic acid bacteria and their bacteriocins: Classification, biosynthesis and applications against Uropathogens: A Mini-Review. Molecules 2017; 22: 1255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Dertli E, Mercan E, Arici M, Yilmaz MT, Sagdic O. Characterisation of lactic acid bacteria from turkish sourdough and determination of their exopolysaccharide (EPS) production characteristics. LWT Food Sci Technol 2016; 71: 116–124. [Google Scholar]
  • 8.Jurášková D, Ribeiro SC, Silva CCG. Exopolysaccharides produced by lactic acid bacteria: from biosynthesis to health-promoting properties. Foods 2022; 11: 156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Wang CL, Huang TH, Liang TW, Fang CY, Wang SL. Production and characterization of exopolysaccharides and antioxidant from Paenibacillus sp. TKU023. N Biotechnol 2011; 28: 559–565. [DOI] [PubMed] [Google Scholar]
  • 10.Liu Z, Zhang Z, Qiu L, Zhang F, Xu X, Wei H, et al. Characterization and bioactivities of the exopolysaccharide from a probiotic strain of Lactobacillus plantarum WLPL04. J Dairy Sci 2017; 100: 6895–6905. [DOI] [PubMed] [Google Scholar]
  • 11.Nehal F, Sahnoun M, Smaoui S, Jaouadi B, Bejar S, Mohammed S. Characterization high production and antimicrobial activity of exopolysaccharides from Lactococcuslactis F-mou. Microb Pathog 2019; 132: 10–19. [DOI] [PubMed] [Google Scholar]
  • 12.Li W, Ji J, Rui X, Yu J, Tang W, Chen X, et al. Production of exopolysaccharides by Lactobacillus helveticus MB2-1 and its functional characteristics in vitro. LWT Food Sci Technol 2014; 59: 732–739. [Google Scholar]
  • 13.Zhou K, Zeng Y, Yang M, Chen S, He L, Ao X, et al. Production, purification and structural study of an exopolysaccharide from Lactobacillus plantarum BC-25. Carbohydr Polym 2016; 144: 205–214. [DOI] [PubMed] [Google Scholar]
  • 14.Zhang L, Liu C, Li D, Zhao Y, Zhang X, Zeng X, et al. Antioxidant activity of an exopolysaccharide isolated from Lactobacillus plantarum C88. Int J Biol Macromol 2013; 54: 270–275. [DOI] [PubMed] [Google Scholar]
  • 15.Riaz Rajoka MS, Wu Y, Mehwish HM, Bansal M, Zhao L. Lactobacillus exopolysaccharides: New perspectives on engineering strategies, physiochemical functions, and immunomodulatory effects on host health. Trends Food Sci Technol 2020; 103: 36–48. [Google Scholar]
  • 16.Rahbar Saadat Y, Yari Khosroushahi A, Pourghassem Gargari B. A comprehensive review of anticancer, immunomodulatory and health beneficial effects of the lactic acid bacteria exopolysaccharides. Carbohydr Polym 2019; 217: 79–89. [DOI] [PubMed] [Google Scholar]
  • 17.Sasikumar K, Kozhummal Vaikkath D, Devendra L. An exopolysaccharide (EPS) from a Lactobacillus plantarum BR2 with potential benefits for making functional foods. Bioresour Technol 2017; 241: 1152–1156. [DOI] [PubMed] [Google Scholar]
  • 18.Ishimwe N, Daliri EB, Lee BH, Fang F, Du G. The perspective on cholesterol lowering mechanisms of probiotics. Mol Nutr Food Res 2015; 59: 94–105. [DOI] [PubMed] [Google Scholar]
  • 19.Michael DR, Davies TS, Moss JWE, Calvente DL, Ramji DP, Marchesi JR, et al. The anti-cholesterolaemic effect of a consortium of probiotics: An acute study in C57BL/6J mice. Sci Rep 2017; 7: 2883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Xiu L, Sheng S, Hu Z, Liu Y, Li J, Zhang H, et al. Exopolysaccharides from Lactobacillus kiferi as adjuvant enhanced the immuno-protective against staphylococcus aureus infection. Int J Biol Macromol 2020; 161: 10–23. [DOI] [PubMed] [Google Scholar]
  • 21.Werning ML, Hernández-Alcántara AM, Ruiz MJ, Soto LP, Dueñas MT, López P, et al. Biological functions of exopolysaccharides from lactic acid bacteria and their potential benefits for humans and farmed animals. Foods 2022; 11: 1284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Tkhruni FN, Karapetyan KJ, Danova ST, Dimova SG, Karimpur FA. Probiotic properties of endemic strains of lactic acid bacteria. J BioSci Biotechnol 2013; 2: 109–115. [Google Scholar]
  • 23.Sørensen HM, Rochfort KD, Maye S, MacLeod G, Brabazon D, Loscher C, et al. Exopolysaccharides of Lactic acid bacteria: Production, purification and health benefits towards functional food. Nutrients 2022; 14: 2938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Bokulich NA, Amiranashvili L, Chitchyan K, Ghazanchyan N, Darbinyan K, Gagelidze N, et al. Microbial biogeography of the transnational fermented milk matsoni. Food Microbiol 2015; 50: 12–19. [DOI] [PubMed] [Google Scholar]
  • 25.Israyelyan AL, Tkhruni FN. Investigation of the properties of endemic LAB strains of genus Enterococcus isolated from samples matsoon. J Biotechnol Biochem 2017; 3: 41–45. [Google Scholar]
  • 26.Cavallarin L, Giribaldi M, de Los Dolores Soto-Del Rio M, Valle E, Barbarino G, Gennero MS, et al. A survey on the milk chemical and microbiological quality in dairy donkey farms located in North Western Italy. Food Control 2015; 50: 230–235. [Google Scholar]
  • 27.Perna A, Intaglietta I, Simonetti A, Gambacorta E. Donkey milk for manufacture of novel functional fermented beverages. J Food Sci 2015; 80: S1352–S1359. [DOI] [PubMed] [Google Scholar]
  • 28.Tkhruni FN, Aghajanyan AE, Balabekyan TR, Khachatryan TV, Karapetyan KJ. Characteristic of bacteriocins of Lactobacillus rhamnosus BTK 20-12 potential probiotic strain. Probiotics Antimicrob Proteins 2020; 12: 716–724. [DOI] [PubMed] [Google Scholar]
  • 29.Parente E, Brienza C, Moles M, Ricciardi A. A comparison of methods for the measurement of bacteriocin activity. J Microbiol Methods 1995; 22: 95–108. [Google Scholar]
  • 30.Bajpai V, Majumder R, Rather IA, Kim K. Extraction, isolation and purification of exopolysaccharide from lactic acid bacteria using ethanol precipitation method. Bangladesh J Pharmacol 2016; 11: 573–576. [Google Scholar]
  • 31.Engvall E. The ELISA, enzyme-linked immunosorbent assay. Clin Chem 2010; 56: 319–320. [DOI] [PubMed] [Google Scholar]
  • 32.Israyelyan A, Balabekyan Ts, Sargsyan Z, Tkhruni F. Effect of some metabiotics from strains of the genus Enterococcus on the growth of pathogenic bacteria that Cause Pneumonia. Biol Bull 2024; 51: 91–97. [Google Scholar]

Articles from Iranian Journal of Microbiology are provided here courtesy of Tehran University of Medical Sciences

RESOURCES